Patent Assignment
Reel/Frame 043086/0831
Change of Name
Recorded: 2017-07-05
Pages: 3
Assignor
DIATECH HOLDINGS, INC.
Executed: 2016-08-28
Assignee
PIERIAN HOLDINGS, INC.
405 DUKE DRIVE, SUITE 240, FRANKLIN, TENNESSEE, 37067
Covered Property
(1)
Biomarkers for Determining Sensitivity of Breast Cancer Cells to HER2-Targeted Therapy
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 29, 2010
From: KIM, PHILLIP; LIU, XINJUN; KIRKLAND, RICHARD; LEE, TANI
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 025556/0182 →
Assignment of Assignor's Interest
Dec 19, 2012
From: PROMETHEUS LABORATORIES INC.
To: NESTEC S.A.
Reel/Frame 029504/0740 →
Assignment of Assignor's Interest
Apr 18, 2017
From: NESTEC S.A.
To: DIATECH HOLDINGS, INC.
Reel/Frame 042045/0220 →
Assignment of Assignor's Interest
Feb 13, 2019
From: PIERIAN HOLDINGS, INC.
To: NESTEC S.A.
Reel/Frame 048322/0411 →
Merger
Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger.
Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →